Status:
COMPLETED
Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients
Lead Sponsor:
University of Colorado, Denver
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Glaucoma is a leading cause of blindness worldwide. Non-adherence to glaucoma medication, which may result in loss of vision, is known to be prevalent. Available information regarding adherence to pre...
Eligibility Criteria
Inclusion
- Diagnosis of primary or secondary open angle glaucoma.
- Currently on monotherapy drop treatment for glaucoma.
- Age \> 18 years.
- Patient has presented for care at the Rocky Mountain Lions Eye Institute Glaucoma Center.
Exclusion
- Inability to independently administer eye drops due to physical disability as reported by the patient.
- Cognitive impairment that would interfere with the ability to self-administer medications as evidenced by a TICS score \< 16.
- Patients who demonstrate \> 80% adherence to glaucoma treatment during the 30 day run-in period.
- It is anticipated that the patient will require glaucoma surgery within the next six months.
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00454922
Start Date
October 1 2007
End Date
January 1 2012
Last Update
December 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rocky Mountain Lions Eye Institute
Aurora, Colorado, United States, 80045